Figure 7
Figure 7. Platelet CD40L transiently disturbs T-cell homeostasis. Flow cytometric analysis of T-cell distribution in blood from adult Apoe−/− mice treated with activated Cd40l+/+Apoe−/− or Cd40l−/−Apoe−/− platelets, or vehicle 12 hours after injection. Percentage of CD4+ T cells (A), CD8+ T cells (B), and CD4+CD25+Foxp3+ regulatory T cells (C). (D) Forty-eight hours after injection of activated platelets, no differences in T-cell phenotype were observed. Anti-CD25 treatment increases atherosclerotic plaque area (E) on injection of Cd40l+/+Apoe−/− platelets and reverses the protective effect of platelet-CD40L deficiency on atherosclerosis. (E) Quantification and (F) representative figures of atherosclerotic plaques in the aortic root of Apoe−/− mice treated with activated Cd40l+/+Apoe−/− or Cd40l−/−Apoe−/− platelets in the absence or presence of an anti-CD25 antibody (n = 30). *P < .05 vs Cd40l+/+Apoe−/−.

Platelet CD40L transiently disturbs T-cell homeostasis. Flow cytometric analysis of T-cell distribution in blood from adult Apoe−/− mice treated with activated Cd40l+/+Apoe−/− or Cd40l−/−Apoe−/− platelets, or vehicle 12 hours after injection. Percentage of CD4+ T cells (A), CD8+ T cells (B), and CD4+CD25+Foxp3+ regulatory T cells (C). (D) Forty-eight hours after injection of activated platelets, no differences in T-cell phenotype were observed. Anti-CD25 treatment increases atherosclerotic plaque area (E) on injection of Cd40l+/+Apoe−/− platelets and reverses the protective effect of platelet-CD40L deficiency on atherosclerosis. (E) Quantification and (F) representative figures of atherosclerotic plaques in the aortic root of Apoe−/− mice treated with activated Cd40l+/+Apoe−/− or Cd40l−/−Apoe−/− platelets in the absence or presence of an anti-CD25 antibody (n = 30). *P < .05 vs Cd40l+/+Apoe−/−.

Close Modal

or Create an Account

Close Modal
Close Modal